HGPI held the third Meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce on the topic of the “The Further Development of Push and Pull Incentives for Innovation.”

Since the achievement of universal health coverage in 1961, the Japanese health system has supported the growth of the one of the healthiest and longest living populations in the world. As that population continues to age, Japan is being presented with a tremendous opportunity: to show the rest of the world how a super-aging society can successfully maintain a national health insurance system that works for all generations, and that can incorporate medical innovations and ensure healthy longevity even under circumstances in which members of the population regularly live to over 100-years of age.

As part of its “Rebalancing Healthcare Systems: Innovation and Sustainability” project, HPGI has formed a taskforce to debate policy measures that can support the achievement of such a system. This taskforce aims to produce an expert report on the health policy opportunities available to Japan within FY2020.

At this third taskforce meeting, taskforce members discussed the various push incentives and pull incentives that could help encourage research and development for health in Japan. Participants debated the general philosophy used thus far within the healthcare system to determine how to allocate limited resources, and the use of both incentives and disincentives to further stimulate research and development.

■Overview
Date and time: Thursday, December 12, 2019
Organizer: HGPI

■Program
Presentation “The Further Development of Push and Pull Incentives for Innovation”
Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)

Taskforce Discussion
Taskforce Members (alphabetical order by last name):
Mamoru Ichikawa (Principal Program Director, Production Center 3 Science Programs Division, Japan Broadcasting Corporation (NHK))
Ataru Igarashi (Associate Professor, Unit of Public Health and Preventive Medicine, Yokohama City University of Medicine / Visiting Associate Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo / Fellow, HGPI)
Satoshi Imamura (Vice-President, Japan Medical Association)
Kyoko Miyahara (Corporate Affairs, Health & Value Lead, Pfizer Japan Inc.)
Toshio Nagase (Senior Director, Government Affairs Japan, Gilead Science K.K.)
Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Naokazu Saito (Director, Policy Intelligence Department, Janssen Pharmaceutical K.K.)
Eiko Shimizu (Project Associate Professor, ITHC, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
Hirokazu Yoshii (Special Advisor to the President, Health Insurance Claims Review & Reimbursement Services)

Moderators:
Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
Joji Sugawara (Senior Associate, HGPI)